BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Diagnosis
858 results:

  • 1. [Ultrasonographic features of thyroid carcinoma of different sizes: comparison between medullary thyroid carcinomas and papillary thyroid carcinomas].
    Zhang D; Yang F; Wang Y; Mu JL; Wei XQ; Wei X
    Zhonghua Zhong Liu Za Zhi; 2024 Feb; 46(2):133-139. PubMed ID: 38418187
    [No Abstract]    [Full Text] [Related]  

  • 2. Neurotrophic-tyrosine receptor kinase gene fusion in papillary thyroid cancer: A clinicogenomic biobank and record linkage study from Finland.
    Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
    Oncotarget; 2024 Feb; 15():106-116. PubMed ID: 38329731
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extent of Surgery for Medullary thyroid cancer and Prevalence of Occult Contralateral Foci.
    Mao YV; Hughes EG; Steinmetz D; Troob S; Kim J; Tseng CH; Fishbein GA; Sajed DP; Livhits MJ; Yeh MW; Lee D; Angell TE; Wu JX
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):209-214. PubMed ID: 38270925
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
    Brandenburg T; Machlah YM; Führer D
    Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Survival Outcomes of Medullary thyroid cancer With and Without Amyloid Deposition.
    Toraih E; Hussein M; Anker A; Baah S; Pinion D; Jishu J; Sadakkadulla S; Case M; LaForteza A; Moroz K; Kandil E
    Endocr Pract; 2024 Apr; 30(4):311-318. PubMed ID: 38184237
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. EphB3 protein is a potential ancillary diagnostic biomarker for thyroid cancers.
    Gao X; Zhang R; He Y; Wang X; Bao W; Feng X; Chai J; Wang J
    Ann Diagn Pathol; 2024 Apr; 69():152262. PubMed ID: 38150866
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. A clinical perspective on ectopic Cushing's syndrome.
    Ragnarsson O; Juhlin CC; Torpy DJ; Falhammar H
    Trends Endocrinol Metab; 2024 Apr; 35(4):347-360. PubMed ID: 38143211
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary thyroid Carcinoma.
    Censi S; Galuppini F; Clausi C; Battheu F; Manso J; Piva I; Corvaglia S; Pedron MC; Mondin A; Iacobone M; Torresan F; Merante Boschin I; Bertazza L; Barollo S; Pennelli G; Mian C
    Thyroid; 2024 Feb; 34(2):177-185. PubMed ID: 38047536
    [No Abstract]    [Full Text] [Related]  

  • 10. Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary thyroid Carcinoma.
    Cavallo AC; Pitoia F; Roberti J; Brenzoni P; Lencioni M; Jaroslavsky MJ; Spengler E; Voogd A; Firpo C; Saco P; Piñero F; Negueruela M
    Thyroid; 2024 Feb; 34(2):186-196. PubMed ID: 38047535
    [No Abstract]    [Full Text] [Related]  

  • 11. A Misleading Case of Ntrk-Rearranged Papillary thyroid Carcinoma.
    Germani MM; Boccaccio C; Matrone A; Molinaro E; Alì G; Giordano M; Elisei R; Fontanini G; Cremolini C
    Oncologist; 2024 Jan; 29(1):84-88. PubMed ID: 38037189
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical characteristics of a large familial cohort with Medullary thyroid cancer and germline Cys618Arg
    Rosenblum RC; Hirsch D; Grozinsky-Glasberg S; Benbassat C; Yoel U; Ishay A; Zolotov S; Bachar G; Banne E; Levy S; Twito O
    Front Endocrinol (Lausanne); 2023; 14():1268193. PubMed ID: 38027168
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Divergent Lineage Markers in Anaplastic thyroid Carcinoma.
    Mneimneh WS; Asa SL
    Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
    Ahmed S; Wedekind MF; Del Rivero J; Raygada M; Lockridge R; Glod JW; Flowers C; Thomas BJ; Bernstein DB; Kapustina OB; Jain A; Miettinen M; Raffeld M; Xi L; Tyagi M; Kim J; Aldape K; Malayeri AA; Kaplan RN; Allen T; Vivelo CA; Sandler AB; Widemann BC; Reilly KM;
    Cancer Res Commun; 2023 Dec; 3(12):2468-2482. PubMed ID: 37966258
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Characterization of the thyroid cancer Genomic Landscape by Plasma-Based Circulating Tumor DNA Next-Generation Sequencing.
    Tarasova VD; Tsai J; Masannat J; Hernandez Prera JC; Hallanger Johnson J; Veloski C; Agosto Salgado S; McIver B; Drusbosky LM; Chung CH
    Thyroid; 2024 Feb; 34(2):197-205. PubMed ID: 37962267
    [No Abstract]    [Full Text] [Related]  

  • 16. An old friend, a new insight: Calcitonin measurement in serum and aspiration needle washout fluids significantly increases the early and accurate detection of medullary thyroid cancer.
    Ogmen BE; Ince N; Aksoy Altınboga A; Akdogan L; Polat SB; Genc B; Menekse E; Aydin C; Topaloglu O; Ersoy R; Cakir B
    Cancer Cytopathol; 2024 Mar; 132(3):161-168. PubMed ID: 37950525
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cabozantinib for different endocrine tumours: killing two birds with one stone. A systematic review of the literature.
    Zago E; Galluzzo A; Pradella S; Antonuzzo L; Maggi M; Petrone L; Sparano C
    Endocrine; 2024 Jan; 83(1):26-40. PubMed ID: 37851242
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Exploring the application value of pro-gastrin-releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma.
    Miao Q; Lv X; Luo L; Zhang J; Cai B
    Cancer Med; 2023 Oct; 12(19):19576-19582. PubMed ID: 37754747
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular imaging and related therapeutic options for medullary thyroid carcinoma: state of the art and future opportunities.
    Imperiale A; Berti V; Burgy M; Cazzato RL; Piccardo A; Treglia G
    Rev Endocr Metab Disord; 2024 Feb; 25(1):187-202. PubMed ID: 37715050
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The novel prognostic nomograms for predicting cancer-specific survival and overall survival in mixed medullary and follicular cell carcinoma: A SEER-based study.
    Li Y; Guo T; Gao X; Liu J
    J Cancer Res Clin Oncol; 2023 Dec; 149(18):16337-16354. PubMed ID: 37704803
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 43.